Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 4 of 4 clinical reviews.
Clinical evidence on Repatha's effect on ALT, including data from FOURIER and post-market surveillance. Learn monitoring protocols, expected changes, and when to act on liver enzyme shifts.
Read clinical reviewEvolocumab reduces apolipoprotein B (ApoB) by 47-52% through PCSK9 inhibition. Learn the mechanism, timeline, trial data from FOURIER, and monitoring recommendations.
Read clinical reviewClinical evidence on Repatha's effect on AST liver enzymes, including data from FOURIER and post-market surveillance, with monitoring recommendations.
Read clinical reviewEvolocumab (Repatha) produces dramatic changes across every line of a standard lipid panel. This evidence-based guide covers LDL-C, HDL-C, triglycerides, total cholesterol, magnitude of change, time course, and monitoring schedules.
Read clinical review